Science, Not Fiction 3: Medicine & Biotechnology

Is the EU doing what it should to truly promote innovation and enable medical advancement? In this edition of SnF, we discussed the main question: How do we capitalise on the rapid development of COVID-19 vaccines and their innovative spillover into new mRNA methods? 

The list of inspiring speakers included:

• Martin Schulz, PhD, Global Senior Medical Director, Gene Therapy Platform, Pfizer
• Šárka Shoup, PhD, Executive Director, Institute for Politics and Society & Board Member, European Liberal Forum
• Isabell Crasto De Stefano, Director, Government & Stakeholder Relations, EMEA, Spectrum Therapeutics, Canopy Growth
• Alexander Natz, Secretary-General, EUCOPE
• Remko Van Leeuwen, Founder & CEO, Madam Therapeutics and Board Member, BEAM Alliance
• Jean-Christophe Pagès, PhD, President, French High Council for Biotechnology (HCB) Scientific Committee& Professor, Cell Biology, CHU & Université Toulouse III
• Annika Szabo Portela, PhD, Collaboration Lead & Deputy Director, EIT Health Scandinavia
• Maya Matthews, Head of Unit (DDG1.B1), Performance of national health systems, DG for Health and Food Safety (DG SANTE), European Commission

Moderated by: Anna Gumbau, EU Affairs reporter

Check out the other two editions of SNF on ”Is healthcare innovation threatened by superbugs” and ”Hardware”.